FMS: Fresenius Medical Care AG & Co. KGaA - Summary | Jitta

Fresenius Medical Care AG & Co. KGaA

NYSE:FMS

Price
$39.37
Loss Chance
44.5%
4.60JITTA SCORE
2.11%Above Jitta Line
Jitta Ranking
65 / 811
1,168 / 4,749
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (49)
Recent Business Performance (33)
Financial Strength (70)
Return to Shareholders (57)
Competitive Advantage (54)
Jitta Signs
Revenue and EarningConsistent
Operating MarginConsistent
Dividend PayoutEvery year
CapExVery High
Key Stats
Jitta Score
Jitta Line
4.60
2.11%
2.38
0.68%
Healthcare Services
1.95
96.55%
2.20
67.48%
6.10
64.45%
COMPANY DESCRIPTION
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, hospitalist, emergency, intensivist, medical cost management, ambulatory surgery center, health plan, urgent care, physician nephrology and cardiology, and ambulant treatment services. The company sells its products to clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of December 31, 2018, it operated 3,928 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.